Loring Wolcott & Coolidge Fiduciary Advisors LLP Laboratory Corp Of America Holdings Transaction History

Loring Wolcott & Coolidge Fiduciary Advisors LLP

$11.1 Billion
Q3 2024

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 01, 2023	SELL	$211.93 - $241.33 $31,577 - $35,958	-149 Reduced 37.34%	250 $60,000
Q1 2022 Apr 13, 2022	BUY	$259.82 - $298.18 $38,713 - $44,428	149 Added 59.6%	399 $105,000
Q2 2021 Aug 13, 2021	BUY	$251.87 - $278.14 $62,967 - $69,535	250 New	250 $69,000
Q1 2021 Apr 14, 2021	SELL	$204.88 - $255.03 $51,220 - $63,757	-250 Closed	0 $0
Q4 2020 Jan 14, 2021	BUY	$186.91 - $214.42 $46,727 - $53,605	250 New	250 $51,000
Q2 2019 Aug 09, 2019	SELL	$144.16 - $172.9 $2,162 - $2,593	-15 Closed	0 $0
Q4 2018 Feb 13, 2019	SELL	$120.82 - $174.09 $12,082 - $17,409	-100 Reduced 86.96%	15 $2,000
Q4 2017 Feb 08, 2018	SELL	$147.99 - $163.95 $22,198 - $24,592	-150 Reduced 56.6%	115 $18,000
Q3 2017 Oct 27, 2017	BUY	$149.47 - $160.56 $2,242 - $2,408	15 Added 6.0%	265 $40,000
Q2 2017 Aug 07, 2017	BUY	N/A	250	250 $0

Others Institutions Holding LH

# of Institutions

Shares Held

1.94M

Call Options Held

Put Options Held

View Full List

About LABORATORY CORP OF AMERICA HOLDINGS

Ticker LH
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 89,600,000
Market Cap $20.5B
Description
Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...

More about LH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Loring Wolcott & Coolidge Fiduciary Advisors LLP, based on Form 13F filings with the SEC.

News

Stay updated on Loring Wolcott & Coolidge Fiduciary Advisors LLP with notifications on news.

Account